Literature DB >> 9396806

The effect of structure in a long target RNA on ribozyme cleavage efficiency.

T B Campbell1, C K McDonald, M Hagen.   

Abstract

Inhibition of gene expression by catalytic RNA (ribozymes) requires that ribozymes efficiently cleave specific sites within large target RNAs. However, the cleavage of long target RNAs by ribozymes is much less efficient than cleavage of short oligonucleotide substrates because of higher order structure in the long target RNA. To further study the effects of long target RNA structure on ribozyme cleavage efficiency, we determined the accessibility of seven hammerhead ribozyme cleavage sites in a target RNA that contained human immunodeficiency virus type 1 (HIV-1) vif - vpr . The base pairing-availability of individual nucleotides at each cleavage site was then assessed by chemical modification mapping. The ability of hammerhead ribozymes to cleave the long target RNA was most strongly correlated with the availability of nucleotides near the cleavage site for base pairing with the ribozyme. Moreover, the accessibility of the seven hammerhead ribozyme cleavage sites in the long target RNA varied by up to 400-fold but was directly determined by the availability of cleavage sites for base pairing with the ribozyme. It is therefore unlikely that steric interference affected hammerhead ribozyme cleavage. Chemical modification mapping of cleavage site structure may therefore provide a means to identify efficient hammerhead ribozyme cleavage sites in long target RNAs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396806      PMCID: PMC147166          DOI: 10.1093/nar/25.24.4985

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library.

Authors:  A Lieber; M Strauss
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

2.  Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA.

Authors:  C Hendrix; J Anné; B Joris; A Van Aerschot; P Herdewijn
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

3.  Influence of substrate structure on cleavage by hammerhead ribozyme.

Authors:  D Scarabino; G P Tocchini-Valentini
Journal:  FEBS Lett       Date:  1996-04-01       Impact factor: 4.124

4.  The effect of base mismatches in the substrate recognition helices of hammerhead ribozymes on binding and catalysis.

Authors:  M Werner; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

5.  Three-dimensional structure of a hammerhead ribozyme.

Authors:  H W Pley; K M Flaherty; D B McKay
Journal:  Nature       Date:  1994-11-03       Impact factor: 49.962

6.  A three-dimensional model for the hammerhead ribozyme based on fluorescence measurements.

Authors:  T Tuschl; C Gohlke; T M Jovin; E Westhof; F Eckstein
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

7.  Synthesis, deprotection, analysis and purification of RNA and ribozymes.

Authors:  F Wincott; A DiRenzo; C Shaffer; S Grimm; D Tracz; C Workman; D Sweedler; C Gonzalez; S Scaringe; N Usman
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

8.  Intracellular susceptibility to ribozymes in a tethered substrate-ribozyme provirus model is not predicted by secondary structures of human immunodeficiency virus type 1 RNAs in vitro.

Authors:  B Dropulić; K T Jeang
Journal:  Antisense Res Dev       Date:  1994

9.  Analysis of the structure of Tetrahymena nuclear RNAs in vivo: telomerase RNA, the self-splicing rRNA intron, and U2 snRNA.

Authors:  A J Zaug; T R Cech
Journal:  RNA       Date:  1995-06       Impact factor: 4.942

10.  Identification of ribozymes within a ribozyme library that efficiently cleave a long substrate RNA.

Authors:  T B Campbell; T R Cech
Journal:  RNA       Date:  1995-08       Impact factor: 4.942

View more
  12 in total

1.  Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.

Authors:  M Amarzguioui; G Brede; E Babaie; M Grotli; B Sproat; H Prydz
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

2.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

3.  A hammerhead ribozyme substrate and reporter for in vitro kinetoplastid RNA editing.

Authors:  Bingbing Wang; Reza Salavati; Stefan Heidmann; Kenneth Stuart
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

4.  Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme.

Authors:  Lucien Junior Bergeron; Jonathan Ouellet; Jean-Pierre Perreault
Journal:  Curr Med Chem       Date:  2003-12       Impact factor: 4.530

5.  Selections for constituting new RNA-protein interactions in catalytic RNP.

Authors:  Shota Atsumi; Yoshiya Ikawa; Hideaki Shiraishi; Tan Inoue
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

6.  Nucleic acid-mediated cleavage of M1 gene of influenza A virus is significantly augmented by antisense molecules targeted to hybridize close to the cleavage site.

Authors:  B Kumar; Madhu Khanna; P Kumar; V Sood; R Vyas; A C Banerjea
Journal:  Mol Biotechnol       Date:  2012-05       Impact factor: 2.695

7.  A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing.

Authors:  Masatora Fukuda; Kei Kurihara; Yasuyoshi Tanaka; Masanobu Deshimaru
Journal:  RNA       Date:  2012-07-13       Impact factor: 4.942

8.  Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.

Authors:  Zhi-Ming Hao; Jin-Yan Luo; Jin Cheng; Quan-Yin Wang; Guang-Xiao Yang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

9.  Trans-cleaving hammerhead ribozymes with tertiary stabilizing motifs: in vitro and in vivo activity against a structured viroid RNA.

Authors:  Alberto Carbonell; Ricardo Flores; Selma Gago
Journal:  Nucleic Acids Res       Date:  2010-11-21       Impact factor: 16.971

10.  Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.

Authors:  Jack M Sullivan; Edwin H Yau; Tiffany A Kolniak; Lowell G Sheflin; R Thomas Taggart; Heba E Abdelmaksoud
Journal:  J Ophthalmol       Date:  2011-06-30       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.